Tesamorelin
20mg · $120 · Current batch
Growth hormone-releasing hormone (GHRH) analog studied in endocrine and metabolic research settings investigating growth hormone secretion and downstream metabolic pathways.
Studied as a GHRH analog in research models of pulsatile growth hormone secretion and downstream IGF-1 and metabolic pathway activity.
Purity≥ 98%
FormLyophilized powder
Size Available20mg (bulk available on request)
StorageStore at -20°C, protect from light and moisture.
Certificate of AnalysisProvided with every batch — request COA · how to read it
This product is sold strictly for in vitro laboratory research use. It is not a drug, dietary supplement, food, or cosmetic, is not intended for human or veterinary use, and has not been evaluated by the FDA. Orders are fulfilled only to verified researchers and institutions. See our research use disclaimer.
Research & References
Published literature relevant to this peptide's studied mechanisms and research use. Provided for reference — not a claim of safety or efficacy for any use outside laboratory research.
- Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men PubMed
- Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials PubMed
- Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial PubMed
